These services include specialized options tailored to various cancer types. The PSMA PET CT scan is designed for prostate ...

PSMA PET scans, for instance, enable precise detection of prostate cancer even in its earliest stages ... significantly ...

Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval: Melbourne, Australia Saturday, January 18, 2025, 10:00 Hrs [IST] Telix Pharmace ...

A new study led by researchers at the UCLA Health Jonsson ... evaluated with advanced prostate-specific membrane antigen-positron emission tomography (PSMA-PET) imaging, suggesting that ...

A new UCLA Health Jonsson Comprehensive Cancer Center-led study has revealed that advanced prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging could reveal ...

A new study led by researchers at the UCLA Health Jonsson ... evaluated with advanced prostate-specific membrane antigen–positron emission tomography (PSMA-PET) imaging, suggesting that ...

Telix’s lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug ...

In morning trade on Friday, the ASX 200 healthcare stock is up 4.5% to a record high of $27.00. Get the latest from The ...

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 16, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...